Milestone Pharmaceuticals Inc.

MIST · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$25,314$13,760$7,636$114,141
Short-Term Investments$44,381$52,243$56,949$0
Receivables$2,391$3,851$1,213$483
Inventory$0$0$0$0
Other Curr. Assets$1,840$3,178$6,005$4,299
Total Curr. Assets$73,926$73,032$71,803$118,923
Property Plant & Equip (Net)$1,573$2,194$2,680$926
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,573$2,194$2,680$926
Other Assets$0$0$0$0
Total Assets$75,499$75,226$74,483$119,849
Liabilities
Payables$1,932$3,981$2,263$4,384
Short-Term Debt$571$546$495$224
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,623$2,699$3,381$2,167
Total Curr. Liab.$8,126$7,226$6,139$6,775
LT Debt$54,226$51,229$1,996$474
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$54,226$51,229$1,996$474
Other Liabilities$0$0$0$0
Cap. Leases$1,445$2,003$1,996$474
Total Liabilities$62,352$58,455$8,135$7,249
Equity
Pref Stock$0$0$0$0
Common Stock$288,048$260,504$273,900$251,901
Retained Earnings-$367,545-$326,026-$266,341-$206,319
AOCI$53,076$48,459$34,352$51,307
Other Equity$39,568$33,834$24,437$15,711
Total Equity$13,147$16,771$66,348$112,600
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$75,499$75,226$74,483$119,849
Net Debt$29,483$38,015-$5,145-$113,443